Evidence check: Glukose in the context of Wechseljahre

The question about glucose in the context of menopause is not directly addressed in the provided knowledge base. Generally, menopause-related hormonal shifts—especially estrogen decline—can reduce insulin sensitivity, leading to higher fasting glucose and increased risk of type 2 diabetes. While MyBody-X may offer tests for glucose-related markers (e.g., HbA1c, fasting glucose) or genetic variants (e.g., TCF7L2), the evidence for their clinical utility in menopause is limited. Most guidelines recommend standard blood work and lifestyle management (diet, exercise) rather than direct-to-consumer tests. A DNA test might reveal small-effect genetic predispositions, but these are not actionable without medical context. I advise consulting a healthcare provider for proper metabolic assessment during perimenopause. Self-tests can provide awareness but not diagnosis. Evidence grade: mechanistic/unclear.